Our previous work identified LGALS3, KLF4, and non-canonical WNTs (i.e., WNT5A), as genes enriched in CTCs from overtly metastatic pancreatic, breast, and prostate cancer mouse models and patients10,11,26. The gene discussed is LGALS3; the disease is prostate carcinoma.